We measured the impact of <i>ANGPTL4</i> overexpression in a common pancreatic cancer cell line, MIA PaCa-2 cells, using CRISPRa for overexpression and DsiRNA for knockdown. The gene discussed is ANGPTL4; the disease is pancreatic neoplasm.